Skip to content
Precision for Medicine
shutterstock_2154471629

Clinical Trial Project Management

Elevate your research with Precision, where every detail is meticulously managed.
At the heart of breakthrough clinical research lies unmatched project management. Discover how Precision for Medicine's approach transforms challenges into triumphs, ensuring your trial's precision from start to finish. Leveraging deep industry knowledge and cutting-edge technology, we are committed to propelling your research forward, delivering impactful therapies to patients who need them most.
# 611310815 Adobe Stock

Innovative research requires innovative project managers

Precision is not just part of our name; it defines our approach to clinical trial project management and execution. Our Project Managers, each bringing an average of 13 years of experience, embody this precision. Their innovative problem-solving and agility is critical to keeping your clinical trial on track. By aligning closely with our sponsors, we help navigate the ever changing landscape at the forefront of research, particularly in groundbreaking areas like Oncology and Rare Diseases. Our expertise is not just about managing trials but pioneering new processes and solutions alongside those we serve, ensuring each study is executed with unmatched precision, creativity and insight. 

Our dedication to excellence and innovation sets us apart, making Precision a pivotal partner in our sponsors' quests for medical breakthroughs. Our specialized team, deeply experienced in Oncology and Rare Diseases, seamlessly turns ambitious visions into realities. This commitment not only differentiates us in the industry but also marks both our paths with lasting impacts on science and patient care.

Precision Project Management: From strategy to success

Begin your clinical trial journey with project managers who prioritize precision, from initial strategy to final analysis. Our partnership is built on a foundation of dedication, expertise, and an uncompromising commitment to patient safety and data integrity.
  • Strategize

    Strategize

    Plan & Design with Precision

    Begin with a strong foundation as our Project Managers synthesize your objectives into a robust Project Management Plan. They ensure meticulous timelines and incorporate safeguards and contingencies, crafting a roadmap tailored for success.
  • Execute

    Execute

    Initiate & Maintain Alignment with Precision

    The journey from planning to action is seamless under our Project Managers' watchful guidance. They work closely with the Precision team to deliver on-time site activation and maintain alignment across all stakeholders, orchestrating cohesion and clarity across all stages of your clinical study.
  • Monitor

    Monitor

    Monitor, Advise & Report with Precision

    Our Project Managers, as an extension of your team, not only oversee the trial's progress but ensure operational excellence. They leverage real-time data and proactive strategies to uphold safety and quality, providing timely advice and comprehensive reports.
  • Deliver

    Deliver

    Finish with Precision

    Your trial concludes with the same detail-oriented precision that it began, culminating in a comprehensive clinical study report and a meticulously maintained trial master file. Every insight gained is poised to enrich your future research.
Clinical Trial Project Manager_at front-v2

Guiding your trials with Precision Principles

Our approach to Clinical Trial Project Management is rooted deeply in the Precision Principles that define our corporate ethos. We view our clients as partners, ensuring that every aspect of our service is delivered with quality, creativity, and innovation. Our team embodies passion and purpose, holding themselves accountable while fostering an environment of mutual respect. Collaboration is key — we work hand-in-hand with you, ensuring integrity and transparency lead our combined efforts. This partnership ethos extends beyond mere collaboration; it is a commitment to shared success, driving forward with mutual goals, and celebrating every milestone in our quest to transform patient lives through groundbreaking research.

Propel your therapy from early insight to late phase impact

  • Discover Early Phase Excellence
    Early Phase Patient

    Early Phase Excellence

    Navigate the complexities of early clinical development with Precision's seasoned Project Managers, where strategic foresight meets diligent execution. Learn more about our early phase solutions.

    Explore
  • Discover Late Phase Success
    Late Phase Success

    Late Phase Success

    Chart your course to approval with late phase trial mastery, guided by our Project Managers' specialized expertise and operational acumen. Learn more about our late phase solutions.

    Explore

Pioneer new therapies with Precision expertise

Navigate our realm of therapeutic and modality expertise, where we propel your pioneering treatments in Oncology, Rare Diseases, and more, from concept to reality.

Specialized capabilities in every stage of clinical development

Leverage an integrated infrastructure that reduces the inefficiencies inherent in complex development. Integrate lab and trial execution to accelerate speed to market. Precision can customize and converge our capabilities to meet your program's unique needs—driving efficiency, agility, and success from start to finish.

  • Discover Explore
    clinical-trial-support

    Global CRO Services

    A recognized leader in oncology and rare diseases with rich experience in complex trials

    Explore
  • Discover Explore
    specialty-lab-services

    Laboratory
    Services

    Experts in translational and biomarker sciences with worldwide specialty labs and clinical logistics services that are enabling breakthroughs.

    Explore

Read the latest insights on Precision’s blog

Discover expert analysis and broaden your understanding through Precision’s Insights on current research, case studies, and trends. 

Read: Why Global Oncology Evidence May Not Support U.S. Regulatory Approval Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

Clinical Trials - Regulatory

Why Global Oncology Evidence May Not Support U.S. Regulatory Approval

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=167363064857, hs_child_table_id=0, hs_updated_at=1719905898183, hs_published_at=1785476963368, description=Industry-leading oncologist and demonstrated medical leader in precision medicine, novel trial design and innovative regulatory initiatives designed to expedite drug approvals. Draws on nearly a decade leading oncology and rare disease programs at the FDA. Former fellow at the National Cancer Institute and frequent featured speaker at ASCO and AACR. CDER technical authority on oncologic drug and biological products for thoracic and head and neck malignancies, neurologic tumors, pediatric solid tumors and rare tumors., avatar=Image{width=553,height=580,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/Headshots/Headshots%20no%20background/Harpreet-Singh2.png',altText='Harpreet-Singh2',fileId=171747124346}, linkedin=https://www.linkedin.com/in/harpreetsinghmd/, team=[{id=163072475007, name='Precision for Medicine Leadership'}], lastname=Singh, MD, hs_initial_published_at=1715692570942, hs_created_by_user_id=2737751, hs_created_at=1715692477118, hs_is_edited=false, hs_deleted_at=0, name=Harpreet, job=Chief Medical Officer, slug=harpreet-singh, hs_updated_by_user_id=65160865}, second={}, third={}})
  • Harpreet Singh, MD avatar

    Harpreet Singh, MD

Discover
Read: Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

Clinical Trials

Early-Phase Oncology Trials in Ireland: Why START Dublin Is a High-Performing Site for Sponsors

|
    has not third author: true, (SizeLimitingPyMap: {main={hs_id=164713188870, hs_child_table_id=0, hs_updated_at=1754641424769, hs_published_at=1785476963368, description=Deana Demjen is Director of the Precision Site Network, bringing nearly 20 years of clinical research to the role. Most of her previous experience has been in feasibility and site-identification. She has been covering a wide range of therapeutic areas, but her main focus are rare diseases where she is an acting subject matter expert. She is responsible for relationships with PSN sites as well as the maintenance and expansion of the network., avatar=Image{width=287,height=287,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/PfM%20Website/PfMxMarkentive/authors/Deana-Demjen-1.png',altText='Deana-Demjen-1',fileId=194123711869}, lastname=Demjen, hs_initial_published_at=1713363230550, hs_created_by_user_id=5166971, hs_created_at=1713363112834, hs_is_edited=false, hs_deleted_at=0, name=Deana, job=Director of PSN, slug=deana-demjen, hs_updated_by_user_id=65160865}, second={}, third={}})
  • Deana Demjen avatar

    Deana Demjen

Discover
Read: Why APAC Is Becoming a Design Decision Why APAC Is Becoming a Design Decision

Clinical Trials

Why APAC Is Becoming a Design Decision

|
    has third author: false, (SizeLimitingPyMap: {main={hs_id=199521241215, hs_child_table_id=0, hs_updated_at=1774887081250, hs_published_at=1785476963368, description=An industry veteran with nearly three decades of experience in the clinical research industry and deep expertise in clinical operations and strategic leadership across both pharmaceutical and CRO environments. Held pivotal roles as Head of Clinical Operations for Greater China at Boehringer Ingelheim, leading trials in oncology, respiratory, stroke, and cardio-metabolic diseases and CEO of George Clinical, a global CRO with strong scientific capabilities in renal and oncology therapeutic areas. At Precision for Medicine, a leader for business strategy across the Asia Pacific region. Focused on driving regional growth, building strategic partnerships, and supporting excellence in portfolio delivery and client satisfaction. An acknowledged driver of precision-driven solutions that improve patient outcomes., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/James%20Cheong.png',altText='James Cheong',fileId=199519079710}, linkedin=https://www.linkedin.com/in/james-cheong-36a543a/, lastname=Cheong, hs_initial_published_at=1762885727645, hs_created_by_user_id=78347666, hs_created_at=1762885637470, hs_is_edited=false, hs_deleted_at=0, name=James, job=Senior Vice President, Asia Pacific, Clinical Solutions​, slug=james-cheong, hs_updated_by_user_id=65160865}, second={hs_id=199519203221, hs_child_table_id=0, hs_updated_at=1770145994248, hs_published_at=1785476963368, description=Highly accomplished global clinical operations executive with nearly three decades of experience providing strategic leadership, regional expansion, and operational excellence across Asia Pacific. Brings deep expertise across clinical development, project and portfolio operations, biometrics, regulatory affairs, safety and pharmacovigilance, quality management, and financial governance. Proven builder and scaler of high‑performing teams and start‑up operations in both regional and global environments. Recognized industry leader who actively contributes to advancing clinical research standards through advisory and governance roles across Asia., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Jing%20Ping%20Yeo.png',altText='Jing Ping Yeo',fileId=199530854290}, linkedin=https://www.linkedin.com/in/jing-ping-yeo/, lastname=Yeo, PhD , hs_initial_published_at=1762893310168, hs_created_by_user_id=78347666, hs_created_at=1762893091367, hs_is_edited=false, hs_deleted_at=0, name=Jing Ping, job=Vice President, Clinical Operations, Head of Asia Pacific​, slug=JingPing-Yeo, hs_updated_by_user_id=65160865}, third={hs_id=199528025104, hs_child_table_id=0, hs_updated_at=1774885968488, hs_published_at=1785476963368, description=With 20+ years of experience in the clinical trial industry, he has led project management, clinical operations, and business development teams. Prior to joining Precision, he served as the General Manager of Emerald (formerly George Clinical) China, and held project management and business development leadership roles at ICON, WuXi CDS, IQVIA, and KUNTUO. He has successfully led teams to complete more than 120 Phase I–IV clinical trials, many of which were MRCT studies across Asia‑Pacific, Australia, and the United States. He holds a Master’s degree in Urology from Peking University First Hospital., avatar=Image{width=276,height=290,url='https://5014803.fs1.hubspotusercontent-na1.net/hubfs/5014803/Zhenfei%20Yin.png',altText='Zhenfei Yin',fileId=199530854553}, lastname=Yin, hs_initial_published_at=1762893310168, hs_created_by_user_id=78347666, hs_created_at=1762893190542, hs_is_edited=false, hs_deleted_at=0, name=Zhenfei, job=China Country Head, Senior Director, Project Management​, slug=Zhenfei Yin, hs_updated_by_user_id=65160865}})
  • James C. avatar Jing Ping Y. avatar Zhenfei Y. avatar
  • James C.

    Jing Ping Y.

    Zhenfei Y.

Discover